企業プロフィール
Corbus Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- CRBP
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
10.69 USD (+2.99%)
終値
最終更新: 2026年8月24日
140M USD
時価総額
株価変動の要因
As of Aug 24, 2026, CRBP closed up 2.99% at $10.69. No new same-company headline was identified in the current news window.
企業概要
事業概要
Corbus Pharmaceuticals is a biotechnology company focused on inflammation, oncology, and endocannabinoid biology. Its story is built around a narrow set of clinical programs and strategic repositioning.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Corbus sits in specialty biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, target selection, and the ability to create a differentiated pipeline in immune disease and cancer.
バイオ業界での位置付け
Corbus is a small-cap catalyst name whose valuation is heavily dependent on program progress.
今後のカタリスト
- Corbus’s catalysts are CRB-701 and CRB-913, with oncology and obesity updates doing most of the work. The company will be judged on whether its next data can support a larger development step.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。